Aldrin Pharma Profile
Key Indicators
- Authorised Capital ₹ 10.00 K
- Paid Up Capital ₹ 10.00 K
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
- Revenue Growth 16.77%
- Profit Growth 42.37%
- Ebitda -4.49%
- Net Worth 96.42%
- Total Assets 49.26%
About Aldrin Pharma
Aldrin Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 April 2017 (Seven years and ten months 17 days old ). Its registered office is in Ahmed Nagar, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 K and a paid-up capital of Rs 10.00 K .
The company currently has active open charges totaling ₹4.00 M.
Neeta Adsul, Vasant Gawate, Sonal Tambe, and One other member serve as directors at the Company.
Company Details
- Location
Ahmed Nagar, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999PN2017PTC169809
- Company No.
169809
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Apr 2017
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
What products or services does Aldrin Pharma Private Limited offer?
Aldrin Pharma Private Limited offers a wide range of products and services, including Health Conditions, Stomach Care.
Who are the key members and board of directors at Aldrin Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeta Adsul  | Director | 07-Apr-2017 | Current |
| Vasant Gawate | Director | 07-Apr-2017 | Current |
| Sonal Tambe | Director | 07-Apr-2017 | Current |
| Surekha Bankar | Director | 13-Sep-2021 | Current |
Financial Performance of Aldrin Pharma.
Aldrin Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.77% increase. The company also saw a substantial improvement in profitability, with a 42.37% increase in profit. The company's net worth Soared by an impressive increase of 96.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aldrin Pharma?
Unlock access to Aldrin Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹4,000,000.00
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Sep 2020 | Hdfc Bank Limited | ₹4.00 M | Open |
How Many Employees Work at Aldrin Pharma?
Aldrin Pharma has a workforce of 16 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aldrin Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aldrin Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.